Agilyx ASA
Agilyx ASA (AGXXF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Agilyx ASA (AGXXF), covering cash flow, earnings, and balance sheets.
Agilyx ASA (AGXXF) Income Statement & Financial Overview
Analyze Agilyx ASA’s AGXXF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $224988.00 | $221392.00 | $7.94M | $4.07M |
| Cost of Revenue | $380699.00 | $374614.00 | $7.33M | $3.76M |
| Gross Profit | -$155711.00 | -$153221.00 | $611685.00 | $313529.00 |
| Gross Profit Ratio | -$0.69 | -$0.69 | $0.08 | $0.08 |
| R&D Expenses | $725686.00 | $714086.00 | $1.69M | $866211.00 |
| SG&A Expenses | $2.30M | $2.26M | $9.53M | $4.88M |
| Operating Expenses | $3.02M | $2.98M | $11.22M | $5.82M |
| Total Costs & Expenses | $3.41M | $3.35M | $18.55M | $9.57M |
| Interest Income | $12313.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $351041.00 | $14782.00 |
| Depreciation & Amortization | $155898.00 | $153406.00 | $397288.00 | $170731.00 |
| EBITDA | -$3.02M | -$2.98M | -$10.02M | -$5.27M |
| EBITDA Ratio | -$13.44 | -$13.44 | -$1.28 | -$1.29 |
| Operating Income | -$3.18M | -$3.13M | -$10.61M | -$5.44M |
| Operating Income Ratio | -$14.14 | -$14.14 | -$1.33 | -$1.33 |
| Other Income/Expenses (Net) | -$2.58M | -$2.53M | -$158188.00 | -$81081.00 |
| Income Before Tax | -$5.76M | -$5.66M | -$10.76M | -$5.52M |
| Income Before Tax Ratio | -$25.58 | -$25.58 | -$1.35 | -$1.35 |
| Income Tax Expense | $1.82M | $0.00 | $1.00 | $0.00 |
| Net Income | -$5.76M | -$5.66M | -$10.76M | -$5.52M |
| Net Income Ratio | -$25.58 | -$25.58 | -$1.35 | -$1.35 |
| EPS | -$0.64 | -$0.06 | -$0.13 | -$0.07 |
| Diluted EPS | -$0.64 | -$0.06 | -$0.13 | -$0.07 |
| Weighted Avg Shares Outstanding | $95.69M | $95.62M | $84.88M | $84.88M |
| Weighted Avg Shares Outstanding (Diluted) | $95.69M | $95.62M | $84.88M | $84.88M |
Over the past four quarters, Agilyx ASA demonstrated steady revenue growth, increasing from $4.07M in Q1 2023 to $224988.00 in Q2 2024. Operating income reached -$3.18M in Q2 2024, maintaining a consistent -1414% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$3.02M, reflecting operational efficiency. Net income dropped to -$5.76M, with EPS at -$0.64. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan